Known targets — ChEMBL curated mechanism
ABL1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB2AGTR1BCL2BCL2A1BCL2L1BCL2L10BCL2L2BCRBRAFCHRM1CHRNA10CHRNA9DRD1DRD2DRD3DRD4DRD5EGFRF2FLT1FLT4GCKGHSRGNRHRGRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BHTR1AHTR1BHTR1DHTR2AHTR2CHTR3AIDH2KDRKITMAOBMCL1MTTPPP4HBPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PIKFYVEROCK1ROCK2SLC18A2SLC6A2SLC6A3SLC6A4TACR1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8gyrAgyrBparCparEpol
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | CASP1 | P29466 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28044265 | 0.75 | — | — | |
| Oxygen SCHEMBL27468735 | 0.73 | — | — | |
| SCHEMBL22434925 | 0.73 | — | — | |
| SCHEMBL27879484 | 0.73 | — | — | |
| SCHEMBL28184335 | 0.73 | — | — | |
| SCHEMBL22993 | 0.73 | — | — | |
| Ethane SCHEMBL28239037 | 0.70 | — | — | |
| Bromide SCHEMBL9054418 | 0.69 | — | — | |
| Ammonia Solution, Strong SCHEMBL22117290 | 0.69 | — | — | |
| Hydrochloric Acid SCHEMBL10373824 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119522874-A | Use of inhibitors for improving placental hypertrophy in cloned animals | 内蒙古大学 | 2025-02-28 | — | — | CN | claimed |
| CN-101862295-A | Aggregate having enhanced deformability and including at least three amphipatic substances | IDEA AG | 2010-10-20 | — | — | CN | claimed |
| CN-120092017-A | Chimeric antigen receptor domains | 提克瓦阿洛塞尔私人有限公司 | 2025-06-03 | — | — | CN | disclosed |
| CN-120076831-A | Anti-ROR 1 antibodies and antibody conjugates, compositions comprising anti-ROR 1 antibodies or antibody conjugates, and methods of making and using anti-ROR 1 antibodies and antibody conjugates | 苏特罗生物制药公司 | 2025-05-30 | — | — | CN | disclosed |
| CN-116157403-B | Morphology of treasiril and method for producing same | 海南先声再明医药股份有限公司 | 2025-04-25 | — | — | CN | disclosed |
| CN-119522874-A | Use of inhibitors for improving placental hypertrophy in cloned animals | 内蒙古大学 | 2025-02-28 | — | — | CN | disclosed |
| CN-111837146-B | G1T38 excellent dosing regimen | G1治疗公司 | 2024-10-15 | — | — | CN | disclosed |
| CN-110913861-B | Morphological forms of G1T38 and methods of making the same | G1治疗公司 | 2024-01-09 | — | — | CN | disclosed |
| CN-112955162-B | Adipocyte-mediated delivery of anticancer therapeutic agents | 北卡罗莱纳州立大学 | 2023-10-13 | — | — | CN | disclosed |
| CN-116157403-A | Morphology of treasiril and method for producing same | G1治疗公司 | 2023-05-23 | — | — | CN | disclosed |
| EP-1656352-A1 | 6-(2,2,2-TRIFLUOROETHYLAMINO)-7-CHLORO-2,3,4,5-TETRAHYDRO-1H-BENZO d AZEPINE AS A 5-HT sb 2c /sb RECEPTOR AGONIST | ELI LILLY AND COMPANY (US) | 2006-05-17 | — | — | EP | disclosed |
| WO-2005019180-A1 | 6-(2,2,2-TRIFLUOROETHYLAMINO)-7-CHLORO-2,3,4,5-TETRAHYDRO-1H-BENZO[d]AZEPINE AS A 5-HT2c RECEPTOR AGONIST | ELI LILLY AND COMPANY (US) | 2005-03-03 | — | — | WO | disclosed |